Efficacy and safety of liraglutide added to insulin therapy in elderly patients with type 2 diabetes

Endocrinology, Diabetes & Metabolism
Mie TonoikeMitsuhiko Noda

Abstract

The combination of GLP-1 receptor agonists and insulin is effective in type 2 diabetes (T2D) treatment. However, its longitudinal efficacy and safety in elderly patients have not been established. We evaluated whether liraglutide (Lira) added to insulin therapy safely improved glycaemic control in T2D patients aged >65 years. Twenty T2D patients receiving insulin were recruited, and Lira was added to their treatment regimen. Before and 6 months after Lira was added, we assessed the metabolic parameters and continuous glucose monitoring (CGM) data. Six months after Lira was added, the levels of HbA1c and glycated albumin and body weight were significantly improved, despite the daily doses and number of insulin injections per day being reduced. CGM analysis revealed that the SD and AUC of glucose >180 mg/dL were significantly decreased; the proportion of hypoglycaemic events was not increased. Lira administration safely improved glycaemic control and reduced body weight. Lira added to insulin therapy may improve the quality of life in elderly T2D patients undergoing insulin therapy, especially those requiring social support.

References

Nov 15, 2006·The Diabetes Educator·Catherine Carver
Jan 30, 2008·Archives of Internal Medicine·Frank A SloanMark N Feinglos
Sep 16, 2009·International Journal of Clinical Practice. Supplement·T Kunt, F J Snoek
Apr 20, 2010·Journal of the American Geriatrics Society·Xinzhi ZhangAnn Albright
Aug 14, 2012·Journal of the American Geriatrics Society·Robert J LigthelmJean-François Yale
Feb 26, 2014·World Journal of Diabetes·Bo Ahrén
Jun 14, 2016·The New England Journal of Medicine·Steven P MarsoUNKNOWN LEADER Trial Investigators
Aug 25, 2017·Current Medical Research and Opinion·Ronald M Goldenberg, Lori Berard
Sep 30, 2017·The Lancet. Gastroenterology & Hepatology·Houssam HalawiMichael Camilleri
Dec 10, 2017·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Apr 23, 2020·Journal of Family Medicine and Primary Care·Ayman A Al Hayek, Mohamed A Al Dawish

❮ Previous
Next ❯

Software Mentioned

STATA

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.